Buprenorphine Sub-Dermal Implant (Probuphine®)

Buprenorphine sub-dermal implant (Probuphine®)

Buprenorphine sub-dermal implant, marketed under the brand name Probuphine®, is a medication used to treat opioid addiction and dependence. It is a small implant placed just under the skin of the upper arm and delivers a steady dose of buprenorphine over six months.

The implant consists of four small rods inserted under the skin using a minimally invasive procedure. The rods slowly release buprenorphine into the bloodstream, providing a consistent and reliable source of medication without the need for daily dosing.

Probuphine® is only available through a restricted program called the Probuphine® REMS (Risk Evaluation and Mitigation Strategy) program, requiring healthcare providers to undergo special training before prescribing it. Patients must also meet specific criteria before they can receive treatment with Probuphine.

Common side effects of buprenorphine include constipation, nausea, headache, and sweating. It may also cause drowsiness or dizziness, so individuals should not drive or operate heavy machinery until they know how the medication affects them.

It is essential to inform healthcare providers of all medications, supplements, and vitamins, as buprenorphine may interact with other medications. Additionally, buprenorphine can cause physical dependence, so it should only be taken under the guidance of a healthcare provider and should not be stopped abruptly.

Overall, buprenorphine sub-dermal implant, including Probuphine®, is an effective medication for treating opioid addiction and dependence. However, working closely with a healthcare provider and following the treatment plan carefully to achieve the best outcomes is essential.

Share your support for mental health
Buprenorphine sub-dermal implant (Probuphine®)

Search Buprenorphine Sub-Dermal Implant (Probuphine®) Mental Health and Substance Abuse Facilities

Select State and State
State
City
Facility Focus
Language Services
Select Options
Language Services
Type Of Care
Select Options
Type Of Care
Telemedicine
Select Options
Telemedicine
Service Settings
Select Options
Service Settings
Facility Type
Select Options
Facility Type
Facility Operations
Select Options
Facility Operations
Payment Assistance Available
Select Options
Payment Assistance Available
Ancillary Services
Select Options
Ancillary Services
Tobacco/Screening Services
Select Options
Tobacco/Screening Services
Age Groups Accepted
Select Options
Age Groups Accepted
Exclusive Services
Select Options
Exclusive Services
Pharmacotherapies
Select Options
Pharmacotherapies
Treatment Approaches
Select Options
Treatment Approaches
Emergency Mental Health Services
Select Options
Emergency Mental Health Services
Special Programs/Groups Offered
Select Options
Special Programs/Groups Offered
Screening & Testing
Select Options
Screening & Testing
Insurance/Funding Accepted/Payment
Select Options
Insurance/Funding Accepted/Payment
Facility Smoking Policy
Select Options
Facility Smoking Policy
License/Accreditation
Select Options
License/Accreditation
Hospitals
Select Options
Hospitals
Type of Opioid Treatment
Select Options
Type of Opioid Treatment
Assessment/Pre-treatment
Select Options
Assessment/Pre-treatment
Transitional Services
Select Options
Transitional Services
Opioid Medications used in Treatment
Select Options
Opioid Medications used in Treatment
External Opioid Medications Source
Select Options
External Opioid Medications Source
Other Addictions
Select Options
Other Addictions
Detoxification
Select Options
Detoxification
Counseling Services and Education
Select Options
Counseling Services and Education
Medical Services
Select Options
Medical Services
Type of Alcohol Use Disorder Treatment
Select Options
Type of Alcohol Use Disorder Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Select Options
External Source of Medications Used for Alcohol Use Disorder Treatment
Gender Accepted
Select Options
Gender Accepted